P49 A REAL‐WORLD RETROSPECTIVE‐PROSPECTIVE ANALYSIS OF EFFICACY AND SAFETY OF COMBINED IXAZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: THE NORTHER... von Furlan, A., Cea, M., Zambello, R., Pavan, L., Galli, M, Clissa, C., Mangiacavalli, S., Cafro, A., Girlanda, S., Patriarca, F., Minotto, C., Bertoldero, G., Barilà, G., Pascarella, A., Lico, A., Paolini, R., Rabassi, N., Pescosta, N., Porrazzo, M., De Sabbata, G., Pompa, A., Bega, G., Cavallin, S., Guidotti, F., Semenzato, G., Zaina, C., Gherlinzoni, F.

Volltext

LONG‐TERM EFFICACY AND SAFETY OF LENALIDOMIDE MAINTENANCE IN PATIENTS WITH RELAPSED DIFFUSE LARGE B‐CELL LYMPHOMA WHO ARE NOT ELIGIBLE FOR AUTOLOGOUS TRANSPLANTATION (ASCT) von Ferreri, A.J., Sassone, M.C., Angelillo, P., Zaja, F., Re, A., Spina, M., Di Rocco, A., Fabbri, A., Stelitano, C., Frezzato, M., Rusconi, C., Zambello, R., Arcari, A., Bertoldero, G., De Lorenzo, D., Volpetti, S., Calimeri, T., Perrone, S., Cecchetti, C., Ciceri, F., Ponzoni, M.

Volltext

POD24 AND CR30 ARE PROMISING SURROGATE ENDPOINTS FOR ASSESSING THE OUTCOME OF PATIENTS WITH ADVANCED STAGE FOLLICULAR LYMPHOMA ENROLLED IN THE FOLL05 TRIAL BY FIL von Luminari, S., Marcheselli, L., Manni, M., Anastasia, A., Vitolo, U., Chiarenza, A., Rigacci, L., Angelucci, E., Fama, A., Pulsoni, A., Rattotti, S., Angrilli, F., Gaidano, G., Stelitano, C., Bertoldero, G., Cascavilla, N., Salvi, F., Ferreri, A.J., Tarantino, V., Bellei, M., Federico, M.

Volltext

LONG TERM RESULTS OF THE FOLL05 RANDOMIZED STUDY COMPARING R‐CVP WITH R‐CHOP AND R‐FM AS FIRST LINE THERAPY IN PATIENTS WITH ADVANCED STAGE FOLLICULAR LYMPHOMA. A FIL STUDY von Luminari, S., Tarantino, V., Anastasia, A., Boccomini, C., Chiarenza, A., Rigacci, L., Angelucci, E., Ferrari, A., Pulsoni, A., Rattotti, S., Angrilli, F., Gaidano, G., Stelitano, C., Bertoldero, G., Cascavilla, N., Salvi, F., Ferreri, A.J., Vallisa, D., Balzarotti, M., Cox, M.C., Freilone, R., Marcheselli, L., Dondi, A., Manni, M., Federico, M.

Volltext

The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study von Rossi, Davide, Bruscaggin, Alessio, La Cava, Piera, Galimberti, Sara, Ciabatti, Elena, Luminari, Stefano, Rigacci, Luigi, Tucci, Alessandra, Pulsoni, Alessandro, Bertoldero, Giovanni, Vallisa, Daniele, Rusconi, Chiara, Spina, Michele, Arcaini, Luca, Angrilli, Francesco, Stelitano, Caterina, Merli, Francesco, Gaidano, Gianluca, Federico, Massimo, Palumbo, Giuseppe A

Volltext

Occurrence of second neoplasms in chronic lymphocytic leukemia. Experience at Padua Hospital between 1979 and 1991 von Bertoldero, G, Scribano, G, Podda, L, Berti, R, Amadori, G

Volltext

Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation in Metastatic Colorectal Cancer as a Novel Adoptive Cell Therapy Approach. The European Group for Blood and Mar... von Aglietta, Massimo, Barkholt, Lisbeth, Schianca, Fabrizio Carnevale, Caravelli, Daniela, Omazic, Brigitta, Minotto, Coludia, Leone, Francesco, Hentschke, Patrik, Bertoldero, Giovanni, Capaldi, Antonio, Ciccone, Giovannino, Niederwieser, Dietger, Ringdén, Olle, Demirer, Tanner

Volltext